Australia markets open in 4 minutes

IQVIA Holdings Inc. (IQV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
160.54-0.50 (-0.31%)
At close: 4:03PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close161.04
Open160.05
Bid155.00 x 1100
Ask166.99 x 900
Day's range159.01 - 161.04
52-week range81.79 - 169.14
Volume680,875
Avg. volume1,204,941
Market cap30.707B
Beta (5Y monthly)1.33
PE ratio (TTM)239.97
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
Press releases
  • Business Wire

    IQVIA’s Nancy Dreyer and Deepa Desai Honored with 2020 PharmaVOICE Awards

    IQVIA™ (NYSE: IQV) today announced that Nancy Dreyer, chief scientific officer and senior vice president, Real World Solutions, has been awarded PharmaVOICE magazine’s Red Jacket honor after she was recognized multiple times as a PharmaVOICE 100. IQVIA’s Deepa Desai, vice president and head, Quality Management Systems, Quality Assurance, was honored on the 2020 PharmaVOICE 100 List, which identifies the most influential and inspiring leaders within the life sciences industry.

  • Business Wire

    Drug Prices Have Become More Affordable to Most Patients, says U.S. Medicine Spending Study from the IQVIA Institute for Human Data Science

    The vast majority of patients in the United States are experiencing lower out-of-pocket costs for their drugs, paying a smaller share of costs and seeing a downward trend in their costs on average. That’s according to the latest report from The IQVIA™ Institute for Human Data Science, Medicine Spending and Affordability in the U.S.: Understanding Patient Costs for Medicines. The improved affordability for patients is due to changes in health insurance benefit design, a higher use of generics, record low price increases on branded drugs and more patients reaching "catastrophic" coverage levels.

  • Business Wire

    IQVIA Launches OCE Optimizer to Help Intelligently Plan HCP Engagements and Maximize Commercial Effectiveness

    IQVIA™ (NYSE: IQV) today introduced OCE Optimizer, an innovative solution that empowers life sciences companies to plan and refine marketing engagements with healthcare providers (HCPs) on demand. OCE Optimizer extends IQVIA’s Orchestrated Customer Engagement solution by intelligently allocating commercial resources and interaction channels for more effective connections.